Evidence map›Paper›PMID 41113750›Full record

ArticleInternational archives of otorhinolaryngology2025

Post-COVID-19 Dysphonia: Risk, Voice Handicap, and Laryngological Findings in COVID-19 Critical Illness Survivors.

Juliana Alves Souza, Carla Aparecida Cielo, Bruna Franciele da Trindade Gonçalves, Élisson Krug Oliveira, Aloma Jacobi Dalla Lana, Adriane Shmidt Pasqualoto

Abstract read
In one paragraph

Article in International archives of otorhinolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juliana Alves SouzaDepartment of Speech Therapy and Human Communication Disorders, Federal University of Santa Maria, Santa Maria, RS, Brazil.ORCID 0000-0003-1239-2112
Carla Aparecida CieloDepartment of Speech Therapy and Human Communication Disorders, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Bruna Franciele da Trindade GonçalvesMultiprofessional Residency Program, Health Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Élisson Krug OliveiraMedical Residency Program in Otorhinolaryngology, Health Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Aloma Jacobi Dalla LanaMedical Residency Program in Otorhinolaryngology, Health Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Adriane Shmidt PasqualotoDepartment of Physiotherapy and Human Communication Disorders, Federal University of Santa Maria, Santa Maria, RS, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate and relate the risk of dysphonia, voice handicap, and laryngological findings in COVID-19 critical illness survivors, stratified by sex and the need for orotracheal intubation (OTI) during hospitalization in the intensive care unit. Additionally, identify predictors of voice symptoms after COVID-19 critical illness. Methods: A cross-sectional study included 50 patients (mean age 51.70 ± 11.90 years; 26 women and 24 men) from a post-COVID-19 Rehabilitation Outpatient Clinic. Evaluations for voice symptoms and dysphonia risk were conducted using the Screening Index for Voice Disorder, vocal handicap using the Voice Handicap Index, and laryngeal health via laryngoscopic examination. Results: Dysphonia risk and voice handicap were significantly more frequent in women. There was no significant association between voice self-assessment instruments and OTI. However, voice symptoms were significantly higher in intubated women. Commonly reported voice symptoms included dry throat, throat clearing, hoarseness, and vocal fatigue. Intubation was associated with laryngeal disorders, particularly in women, with the hypopharyngeal and supraglottic regions more affected by erythema and edema. Female gender, dyspnea, and cough accounted for 51% of the variance in voice symptoms. Conclusions: COVID-19 critical illness survivors reported dry throat, throat clearing, hoarseness, and vocal fatigue even four months post-discharge. Women were at greater risk of dysphonia and voice handicaps. More than a quarter of patients presented laryngeal disorders related to OTI. Female gender and persistent symptoms of cough and dyspnea were predictors of voice symptoms. These findings enhance understanding of COVID-19's impact on the voice, highlighting the need for multidisciplinary approaches.

Indexed as

COVID-19dysphoniaintensive care unitslarynxvoicevoice disorders

Identifiers

PMID41113750
PMCPMC12530912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.